Nyxoah (NYXH) announced the commercial launch of its Genio system in the Middle East, marked by the first successful Genio implant performed at ...

We came across a bullish thesis on Organigram Holdings Inc. (OGI) on Substack by Jake LaMotta. In this article, we will ...

Tilray Brands' net debt significantly reduced from $309 million to $31 million over the past year. Read why TLRY stock is ...

Atb Cap Markets reduced their Q3 2025 EPS estimates for shares of Organigram in a research report issued to clients and investors on Tuesday, February 11th. Atb Cap Markets analyst F. Gomes now ...

Equities research analysts at Atb Cap Markets dropped their Q3 2025 EPS estimates for shares of Organigram in a report issued on Tuesday, February 11th. Atb Cap Markets analyst F. Gomes now forecasts ...

Investors poured $61 million into a cannabis cultivation scheme that regulators say funded luxury cars instead of marijuana grow sites.

Management sees German medical market quadrupling as it awaits key EU certification and works to boost production capacity.

Q1 2025 Earnings Call Transcript February 11, 2025 OrganiGram Holdings Inc. misses on earnings expectations. Reported EPS is $-0.2 EPS, expectations were $-0.03. Operator: Good morning. My name is ...

Following the company’s first quarter results, Haywood analyst Neal Gilmer has cut his price target on Organigram.

On Tuesday, Cannabis producer Organigram Holdings Inc reported first-quarter 2025 gross sales of CA$66.8 million, up 19% year-over-year, beating the consensus of CA$65.4 million. 21% of harvests came ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Royalty Pharma (RPRX – Research Report), ...